Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3-Avadel Pharmaceuticals plc

9th Jan 2026 11:10

RNS Number : 3613O
Bank of America Merrill Lynch
09 January 2026
 

FORM 8.3

 

IRISH TAKEOVER PANEL

 

OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER

RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

 

1. KEY INFORMATION

 

(a) Full name of discloser

Bank of America Corporation

(b) Owner or controller of interests and short positions disclosed, if different from 1(a)

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates

Use a separate form for each offeror/offeree

AVADEL PHARMACEUTICALS PLC

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree (Note 1)

(e) Date position held/dealing undertaken

For an opening position disclosure, state the latest practicable date prior to the disclosure

08/01/2026

(f) In addition to the company in 1(c) above, is the discloser also making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

No

 

 

 

 

 

2. INTERESTS AND SHORT POSITIONS

 

If there are interests and short positions to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2 for each additional class of relevant security.

Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

(Note 2)

 

Class of relevant security (Note 3)

0.01 ordinary shares

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled

1,826,059

1.875%

386,524

0.397%

(2) Cash-settled derivatives

339,928

0.349%

38,920

0.040%

(3) Stock-settled derivatives (including options) and agreements to purchase/ sell

0

0.000%

0

0.000%

Total

2,165,987

2.224%

425,444

0.437%

 

All interests and all short positions should be disclosed.

 

Details of options including rights to subscribe for new securities and any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8.

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE (Note 4)

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Purchase

24

21.41 USD

USD 0.01 common

Purchase

4

21.43 USD

USD 0.01 common

Purchase

1,606

21.44 USD

USD 0.01 common

Purchase

1,200

21.4475 USD

USD 0.01 common

Purchase

1,518

21.4495 USD

USD 0.01 common

Purchase

9,317

21.45 USD

USD 0.01 common

Purchase

3,269

21.450401 USD

USD 0.01 common

Purchase

900

21.455 USD

USD 0.01 common

Purchase

708

21.46 USD

USD 0.01 common

Purchase

51

21.460589 USD

USD 0.01 common

Purchase

26

21.464231 USD

USD 0.01 common

Purchase

622

21.465 USD

USD 0.01 common

Purchase

23

21.465653 USD

USD 0.01 common

Purchase

26

21.466924 USD

USD 0.01 common

Purchase

23

21.468261 USD

USD 0.01 common

Purchase

30

21.469334 USD

USD 0.01 common

Purchase

4,551

21.47 USD

USD 0.01 common

Purchase

20

21.474 USD

USD 0.01 common

Purchase

25

21.4748 USD

USD 0.01 common

Purchase

4,916

21.475 USD

USD 0.01 common

Purchase

23

21.475218 USD

USD 0.01 common

Purchase

22

21.476819 USD

USD 0.01 common

Purchase

37

21.478379 USD

USD 0.01 common

Purchase

24

21.47875 USD

USD 0.01 common

Purchase

29

21.479656 USD

USD 0.01 common

Purchase

34,437

21.48 USD

USD 0.01 common

Purchase

986

21.485 USD

USD 0.01 common

Purchase

13

21.485385 USD

USD 0.01 common

Purchase

300

21.4875 USD

USD 0.01 common

Purchase

30,769

21.49 USD

USD 0.01 common

Purchase

17,504

21.495 USD

USD 0.01 common

Purchase

93

21.495054 USD

USD 0.01 common

Purchase

41,467

21.5 USD

USD 0.01 common

Purchase

12

21.47 USD

USD 0.01 common

Purchase

162,024

21.48 USD

 

 

Class of relevantsecurity

Purchase/sale

Number ofsecurities

Price per unit (Note 5)

USD 0.01 common

Sale

1,484

21.442197 USD

USD 0.01 common

Sale

5

21.47 USD

USD 0.01 common

Sale

1,078

21.48 USD

USD 0.01 common

Sale

149,647

21.45 USD

USD 0.01 common

Sale

6

21.47 USD

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description e.g. CFD

Nature of dealing e.g. opening/ closing a long/ short position, increasing/ reducing a long/ short position

Number of reference securities (Note 6)

Price per unit (Note 5)

 

 USD

USD 0.01 common

Swaps

Increasing a short position

5

21.4402

USD 0.01 common

Swaps

Increasing a short position

1518

21.4497

USD 0.01 common

Swaps

Reducing a short position

292

21.442

USD 0.01 common

Swaps

Closing a Long Position

162004

21.48

USD 0.01 common

Swaps

Reducing a short position

5

21.4698

USD 0.01 common

Swaps

Increasing a short position

3269

21.4506

USD 0.01 common

Swaps

Reducing a short position

1192

21.442

 

 

(c) Stock-settled derivative transactions (including options)

 

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates (Note 6)

Exerciseprice per unit

Type e.g. American, Europeanetc.

Expiry date

Option moneypaid/ received per unit

N/A

N/A

N/A

N/A

N/A

N/A

N/A

N/A

 

(ii) Exercise

 

Class of relevant security

Product description e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit (Note 5)

N/A

N/A

N/A

N/A

N/A

 

(d) Other dealings (including transactions in respect of new securities) (Note 3)

 

Class of relevant security

Nature of dealing e.g. subscription, conversion, exercise

Details

Price per unit (if applicable) (Note 5)

N/A

N/A

N/A

N/A

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer.

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

 

 

(c) Attachments

 

Is a Supplemental Form 8 attached?

No

 

Date of disclosure

09/01/2026

Contact name

Kamil Dziedzic

Telephone number

+353 86 168 4821

 

Public disclosures under Rule 8.3 of the Rules must be made to a Regulatory Information Service.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ITPFKLFBQFLBBBD
FTSE 100 Latest
Value10,124.60
Change79.91